Physician profile
Saduff Nawabzada
NPI 1265261846
$1,008.79
in general payments reported to CMS, 2019-2025
14 companies · $699 in 2025
The $699 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $309 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $269.67 | 2024-2025 | |
| Hologic Sales and Service, LLC | $184.22 | 2024-2025 | Aptima, Acessa Provu System, Thinprep 2000 Processor |
| Astellas Pharma US INC | $149.98 | 2025 | Veozah |
| Daiichi Sankyo INC. | $93.66 | 2024-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $58.67 | 2024-2025 | |
| Sage Therapeutics, LLC | $50.51 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $38.64 | 2024-2025 | Slynd |
| Sumitomo Pharma America, INC. | $33.91 | 2024-2025 | Myfembree |
| Octapharma USA, INC. | $29.00 | 2025 | Fibryga |
| Optumhealth Care Solutions, LLC | $27.88 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $23.58 | 2024 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $19.45 | 2025 | Qelbree |
| Exact Sciences Corporation | $15.98 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $13.64 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saduff Nawabzada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.